SOLV vs XRAY
SOLV: A diversified healthcare technology and medical products company formed to drive innovation in clinical care, dental health, and health information management. XRAY: The world's largest diversified dental equipment and consumables manufacturer, integrating cloud-based digital workflows with traditional treatment solutions across 140 countries.
Side-by-side fundamentals
| Metric | SOLV | XRAY | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $77.64 | $13.27 | |
| Market cap as of 2026-07-23 | $13.4B | $2.9B | |
| P/E as of 2026-07-23 | 9.39 | n/a | |
| PEG as of 2026-07-23 | 0.03 | 1.58 | SOLV lower |
| Net margin as of 2026-07-23 | +17.3% | -17.1% | SOLV higher |
| Gross margin as of 2026-07-23 | +53.7% | +48.9% | SOLV higher |
| Operating margin as of 2026-07-23 | +24.5% | -14.1% | SOLV higher |
| ROE as of 2026-07-23 | +30.7% | -41.2% | SOLV higher |
| ROA as of 2026-07-23 | +10.0% | -11.2% | SOLV higher |
| Debt / equity as of 2026-07-23 | 1.06 | 1.70 | SOLV lower |
| Revenue growth (YoY) as of 2026-07-23 | -0.6% | -1.0% | SOLV higher |
| Revenue CAGR (3y) SEC XBRL | +0.8% | -2.1% | SOLV higher |
| Dividend yield as of 2026-07-23 | n/a | +5.5% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 0.57 | 0.87 | |
| 1-year return as of 2026-07-22 close | +6.5% | -19.1% | SOLV higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.